Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry

被引：0

作者：

Diaz Gonzalez, Alvaro ^{[1
]}

Gonzalez Pascual, Andrea ^{[1
]}

Gomez-Camarero, Judith ^{[2
]}

Gomez Dominguez, Elena ^{[3
]}

Carlota Londono, Maria ^{[4
]}

Vergara Gomez, Mercedes ^{[5
]}

Ampuero, Javier ^{[6
]}

Martinez, Javier ^{[7
]}

Horta, Diana ^{[8
]}

Gallego, Adolgo ^{[9
]}

Salmeron, Javier ^{[10
]}

Garcia-Retortillo, Montserrat ^{[11
]}

Morillas, Rosa M. ^{[12
]}

Andrade, Raul J. ^{[13
]}

Turnes, Juan ^{[14
]}

Diago, Moises ^{[15
]}

El Hajra Martinez, Ismael ^{[16
]}

Roget Alemany, Merce ^{[17
]}

Hernandez Guerra, Manuel ^{[18
]}

Quintans, Nerea ^{[19
]}

Sala, Margarita ^{[20
]}

Dominguez, Nuria ^{[21
]}

Arencibia Almeida, Ana ^{[22
]}

Crespo, Javier ^{[1
]}

Barreira, Ana ^{[23
]}

Salcedo, Magdalena ^{[24
]}

Riveiro Barciela, Mar ^{[23
]}

机构：

[1] Hosp Univ Marques Valdecilla, Dept Gastroenterol & Hepatol, Grp Invest Clin & Traslac Enfermedades Digest, Inst Invest Valdecilla IDIVAL, Santander, Spain

[2] Burgos Univ Hosp, Burgos, Spain

[3] Univ Hosp October 12, Madrid, Spain

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] Hosp Parc Tauli Sabadell, Sabadell, Spain

[6] Virgen Del Rocio Univ Hosp, Seville, Spain

[7] Ramon & Cajal Hosp, Madrid, Spain

[8] Hosp Univ MutuaTerrassa, Terrassa, Spain

[9] Hosp Santa Creu & St Pau Church, Barcelona, Spain

[10] Hosp Univ Clin San Cecilio, Granada, Spain

[11] Hosp Mar, Barcelona, Spain

[12] Germans Trias & Pujol Hosp, Badalona, Spain

[13] Hosp Univ Virgen Victoria, Malaga, Spain

[14] Complejo Univ Hosp Pontevedra, Pontevedra, Spain

[15] Consortium Gen Univ Hosp Valencia, Valencia, Spain

[16] Puerta De Hierro Majadahonda Univ Hosp, Majadahonda, Spain

[17] Consorci Sanitari Terrassa, Terrassa, Spain

[18] Hosp Univ Canarias, San Cristobal la Laguna, Spain

[19] Alvaro Cunqueiro Hosp, Vigo, Spain

[20] Hosp Univ Josep Trueta, Girona, Spain

[21] Hosp Infanta Cristina, Madrid, Spain

[22] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain

[23] Hosp Valle De Hebron, Barcelona, Spain

[24] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-264

引用

页码：S376 / S377

页数：2

共 50 条

[31] Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
Benjamin D. Liu
Kamran Qureshi
Digestive Diseases and Sciences, 2023, 68 : 346 - 348
[32] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
Tanaka, Atsushi
Hirohara, Junko
Nakano, Toshiaki
Yagi, Minami
Namisaki, Tadashi
Yoshiji, Hitoshi
Nakanuma, Yasuni
Takikawa, Hajime
HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
[33] Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis
Matsumoto, Kosuke
Hirohara, Junko
Takeuchi, Akihito
Miura, Ryo
Asaoka, Yoshinari
Nakano, Toshiaki
Tanaka, Atsushi
HEPATOLOGY RESEARCH, 2023, 53 (10) : 989 - 997
[34] EFFECT OF FIBRATE-ADD-ON TREATMENT IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH AN INSUFFICIENT RESPONSE TO URSODEOXYCHOLIC ACID
Freissmuth, C.
Kozbial, K.
Staettermayer, A. F.
Beinhardt, S.
Stern, R.
Halilbasic, E.
Ferenci, P.
Trauner, M.
Hofer, H.
JOURNAL OF HEPATOLOGY, 2016, 64 : S434 - S435
[35] Response failure to ursodeoxycholic acid treatment in primary biliary cholangitis is associated with a distinct stool and urine secondary bile acid profile
Martinez-Gili, Laura
Pechlivanis, Alexandros
Begum, Sofina
Mells, George
Holmes, Elaine
Jones, David
JOURNAL OF HEPATOLOGY, 2021, 75 : S404 - S405
[36] EVALUATION OF PROGNOSTIC MODELS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS RECEIVING URSODEOXYCHOLIC ACID
Alomari, Mohammad
Covut, Fahrettin
Chadalavada, Pravallika
Gunasekaran, Deepthi
Padbidri, Vinay S.
Al Momani, Laith
Khazaaleh, Shrouq
Romero-Marrero, Carlos
GASTROENTEROLOGY, 2019, 156 (06) : S1321 - S1321
[37] Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis
John, Binu V.
Khakoo, Nidah S.
Schwartz, Kaley B.
Aitchenson, Gabriella
Levy, Cynthia
Dahman, Bassam
Deng, Yangyang
Goldberg, David S.
Martin, Paul
Kaplan, David E.
Taddei, Tamar H.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (09): : 1913 - 1923
[38] IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate
Takano, Keiko
Saeki, Chisato
Oikawa, Tsunekazu
Hidaka, Akihisa
Mizuno, Yusuke
Ishida, Jinya
Takakura, Kazuki
Nakano, Masanori
Torisu, Yuichi
Amano, Katsushi
Ishikawa, Tomohisa
Zeniya, Mikio
Tsubota, Akihito
Saruta, Masayuki
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (04) : 663 - 672
[39] Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms
Huang, Lin-Xiang
Wang, Zi-Long
Jin, Rui
Chen, Hong-Song
Feng, Bo
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (11-12) : 1065 - 1078
[40] Ciprofibrate: a new option of fibrate for primary biliary cholangitis with incomplete response to ursodeoxycholic acid
Guedes, Laura
Braga, Michele Harriz
Moutinho, Bruna Damasio
Carrilho, Flair Jose
Rachid Cancado, Eduardo Luiz
JOURNAL OF HEPATOLOGY, 2020, 73 : S479 - S479

← 1 2 3 4 5 →